Current Articles | Archived Articles
Articles From The Most Current Issue of OBR
The EMR Landscape: A Review of the ASCO 2010 EHR Lab
Thu, Jul 01, 2010
As the adoption of oncology-focused EMRs gains momentum, the 4th ASCO EHR Lab provided a platform for meeting attendees to learn about different EHR products. With 8 sponsoring companies representing their products, and individual booths for most of the EMR vendors, an attendee had the unique opportunity to learn about the variety of products in one place. In this article from an early adopter of an EMR system, we got his impressions of the ASCO Lab and some of the issues to consider when purchasing one of these systems.[ read article ]
Taking It Personal–When to Add Biomarkers to Treatment Guidelines
Thu, Jul 01, 2010
As cancers continue to be redefined in terms of genetics and other niche markers, the incorporation of biomarkers into treatment guidelines is becoming a vital part of therapeutic decision making. But there are very few “home-run” biomarkers such as HER2 and K-ras, and physicians won’t adopt a new companion biomarker unless they are confident in its clinical relevance. What clinical evidence do we need to add a biomarker into established national treatment guidelines?[ read article ]
Factors Driving the Current and Future Use of Oncology Biomarkers
Thu, Jul 01, 2010
A companion to our focus on biomarkers, a survey from The ARCAS Group (powered by MDoutlook) provides unique perspectives of hem/oncs on the circumstances driving the current and future use of oncology biomarkers.[ read article ]
Innovative Advancements in Treating Cancer: Beyond Targeted Therapies
Thu, Jul 01, 2010
The theme of this year’s ASCO was quality through innovation, and based on presentations at this year’s meeting it appears as though innovation is reaching beyond targeted therapies to include new product classes, novel patient segments, new treatment practices, and inventive devices or methods of drug delivery. Kantar Health reviewed some of the major stories for us on clinical advances and innovations that will hopefully lead to greater quality of care for cancer patients.[ read article ]
ASCO 2010 Top News Stories
Thu, Jul 01, 2010
ASCO is one of the most anticipated and discussed major medical meetings of the year. This year’s meeting did not disappoint. In our review of the top 10 media stories coming out of the meeting, exciting highlights received top priority.[ read article ]
Payer Reactions to Highly Anticipated Clinical Trial Presentations
Thu, Jul 01, 2010
It is always interesting to hear what oncologists think about recent data coming out of ASCO, but what about medical directors at private insurance plans? Assuming that their role is to adopt important new clinical advances into coverage policy while at the same time prevent runaway costs, what did they think of this year’s data? Reimbursement Intelligence provides us with a post-ASCO survey on payers’ perspectives about adoption of new clinical data at the layer level.[ read article ]
On-Currences
Thu, Jul 01, 2010
Tracking the movement of oncology business personnel and other news making events in the oncology community.[ read article ]